Your browser doesn't support javascript.
loading
Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias.
Martínez-Rubio, Dolores; Hinarejos, Isabel; Sancho, Paula; Gorría-Redondo, Nerea; Bernadó-Fonz, Raquel; Tello, Cristina; Marco-Marín, Clara; Martí-Carrera, Itxaso; Martínez-González, María Jesús; García-Ribes, Ainhoa; Baviera-Muñoz, Raquel; Sastre-Bataller, Isabel; Martínez-Torres, Irene; Duat-Rodríguez, Anna; Janeiro, Patrícia; Moreno, Esther; Pías-Peleteiro, Leticia; Gordo, Mar O'Callaghan; Ruiz-Gómez, Ángeles; Muñoz, Esteban; Martí, Maria Josep; Sánchez-Monteagudo, Ana; Fuster, Candela; Andrés-Bordería, Amparo; Pons, Roser Maria; Jesús-Maestre, Silvia; Mir, Pablo; Lupo, Vincenzo; Pérez-Dueñas, Belén; Darling, Alejandra; Aguilera-Albesa, Sergio; Espinós, Carmen.
Afiliação
  • Martínez-Rubio D; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Hinarejos I; Joint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
  • Sancho P; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Gorría-Redondo N; Joint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
  • Bernadó-Fonz R; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Tello C; Paediatric Neurology Unit, Department of Paediatrics, Hospital Universitario de Navarra, Navarrabiomed, 31008 Pamplona, Spain.
  • Marco-Marín C; Paediatric Neurology Unit, Department of Paediatrics, Hospital Universitario de Navarra, Navarrabiomed, 31008 Pamplona, Spain.
  • Martí-Carrera I; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Martínez-González MJ; Structural Enzymopathology Unit, Instituto de Biomedicina de Valencia (IBV), Consejo Superior de Investigaciones Científicas (CSIC), Centro de Investigación Biomédica de Enfermedades Raras (CIBERER-ISCIII), 46010 Valencia, Spain.
  • García-Ribes A; Biodonostia Health Research Institute, Paediatric Group, Donostia University Hospital, Department of Paediatrics, University of the Basque Country UPV/EHU, 20014 San Sebastian, Spain.
  • Baviera-Muñoz R; Paediatric Neurology Unit, Hospital Universitario Cruces, 48903 Barakaldo, País Vasco, Spain.
  • Sastre-Bataller I; Paediatric Neurology Unit, Hospital Universitario Cruces, 48903 Barakaldo, País Vasco, Spain.
  • Martínez-Torres I; Joint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
  • Duat-Rodríguez A; Health Research Institute, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
  • Janeiro P; Movement Disorders Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
  • Moreno E; Joint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
  • Pías-Peleteiro L; Movement Disorders Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
  • Gordo MO; Joint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
  • Ruiz-Gómez Á; Movement Disorders Unit, Neurology Department, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
  • Muñoz E; Paediatric Neurology Unit, Hospital Infantil Universitario Niño Jesús, 28009 Madrid, Spain.
  • Martí MJ; Centro de Referencia de Doenças Hereditarias do Metabolismo, CHULN, Hospital Santa Maria, 1649-035 Lisbon, Portugal.
  • Sánchez-Monteagudo A; Department of Paediatrics, Hospital Regional Universitario, 29010 Malaga, Spain.
  • Fuster C; Paediatric Neurology Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
  • Andrés-Bordería A; Paediatric Neurology Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
  • Pons RM; Department of Paediatrics, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.
  • Jesús-Maestre S; Unit of Parkinson and Movement Disorders, Department of Neurology, Hospital Universitari Clínic, 08036 Barcelona, Spain.
  • Mir P; Unit of Parkinson and Movement Disorders, Department of Neurology, Hospital Universitari Clínic, 08036 Barcelona, Spain.
  • Lupo V; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Pérez-Dueñas B; Joint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
  • Darling A; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Aguilera-Albesa S; Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
  • Espinós C; Paediatric Neurology, Hospital Agia Sofía, 11527 Athens, Greece.
Int J Mol Sci ; 23(19)2022 Oct 06.
Article em En | MEDLINE | ID: mdl-36233161
ABSTRACT
Our clinical series comprises 124 patients with movement disorders (MDs) and/or ataxia with cerebellar atrophy (CA), many of them showing signs of neurodegeneration with brain iron accumulation (NBIA). Ten NBIA genes are accepted, although isolated cases compatible with abnormal brain iron deposits are known. The patients were evaluated using standardised clinical assessments of ataxia and MDs. First, NBIA genes were analysed by Sanger sequencing and 59 patients achieved a diagnosis, including the detection of the founder mutation PANK2 p.T528M in Romani people. Then, we used a custom panel MovDisord and/or exome sequencing; 29 cases were solved with a great genetic heterogeneity (34 different mutations in 23 genes). Three patients presented brain iron deposits with Fe-sensitive MRI sequences and mutations in FBXO7, GLB1, and KIF1A, suggesting an NBIA-like phenotype. Eleven patients showed very early-onset ataxia and CA with cortical hyperintensities caused by mutations in ITPR1, KIF1A, SPTBN2, PLA2G6, PMPCA, and PRDX3. The novel variants were investigated by structural modelling, luciferase analysis, transcript/minigenes studies, or immunofluorescence assays. Our findings expand the phenotypes and the genetics of MDs and ataxias with early-onset CA and cortical hyperintensities and highlight that the abnormal brain iron accumulation or early cerebellar gliosis may resembling an NBIA phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtornos dos Movimentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtornos dos Movimentos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha